Consultant Haematologist
University College London Hospital, England, United Kingdom
Disclosure information not submitted.
Phase 1 Study of the Safety and Pharmacokinetics of CSL889 (Hemopexin) in Adults with SCD
Saturday, June 8, 2024
9:00 AM – 9:15 AM ET
Randomized Phase 1b CROSSWALK-a and Phase 2a CROSSWALK-c Trials – Crovalimab for SCD
Sunday, June 9, 2024
1:33 PM – 1:51 PM ET